Respiratory measuring devices, also known as respirometers, include respirometers, pulse oximeters, carbonic acid meters, and peak flow meters.
Market Analysis and Insights: Global Respiratory Disease Testing & Diagnostics Market
The global Respiratory Disease Testing & Diagnostics market is projected to grow from US$ 4622 million in 2023 to US$ 5165.8 million by 2029, at a Compound Annual Growth Rate (CAGR) of 1.9% during the forecast period.
The prevalence of respiratory diseases such as chronic obstructive pulmonary disease, asthma and other respiratory infections, as well as the increasing popularity of portable devices such as advanced respirometers and non-invasive ventilators are the leading causes of North America.
Report Includes
This report presents an overview of global market for Respiratory Disease Testing & Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Respiratory Disease Testing & Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Respiratory Disease Testing & Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Respiratory Disease Testing & Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Respiratory Disease Testing & Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Respiratory Disease Testing & Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Becton Dickinson, Abbott Laboratories, Abbott, Cepheid, Fischer and Paykel, Futuremed, Hoffmann-La Roche, Instrumentation Laboratories and Medtronic, etc.
By Company
Becton Dickinson
Abbott Laboratories
Abbott
Cepheid
Fischer and Paykel
Futuremed
Hoffmann-La Roche
Instrumentation Laboratories
Medtronic
NDD Medical Technologies
Nihon Kohden
Philips Medical Systems
SDI Diagnostics
Seegene
Smiths Medical
Segment by Type
Imaging Test
Respiratory Measurement
Blood Gas Test
Other
Segment by Application
Hospitals
Physician Clinics
Clinical Laboratories
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Respiratory Disease Testing & Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Disease Testing & Diagnostics companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Respiratory Disease Testing & Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Disease Testing & Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Imaging Test
1.2.3 Respiratory Measurement
1.2.4 Blood Gas Test
1.2.5 Other
1.3 Market by Application
1.3.1 Global Respiratory Disease Testing & Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Physician Clinics
1.3.4 Clinical Laboratories
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Disease Testing & Diagnostics Market Perspective (2018-2029)
2.2 Global Respiratory Disease Testing & Diagnostics Growth Trends by Region
2.2.1 Respiratory Disease Testing & Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Respiratory Disease Testing & Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Respiratory Disease Testing & Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Respiratory Disease Testing & Diagnostics Market Dynamics
2.3.1 Respiratory Disease Testing & Diagnostics Industry Trends
2.3.2 Respiratory Disease Testing & Diagnostics Market Drivers
2.3.3 Respiratory Disease Testing & Diagnostics Market Challenges
2.3.4 Respiratory Disease Testing & Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Respiratory Disease Testing & Diagnostics by Players
3.1.1 Global Respiratory Disease Testing & Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Respiratory Disease Testing & Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Respiratory Disease Testing & Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Respiratory Disease Testing & Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Respiratory Disease Testing & Diagnostics Market Concentration Ratio
3.4.1 Global Respiratory Disease Testing & Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Disease Testing & Diagnostics Revenue in 2022
3.5 Global Key Players of Respiratory Disease Testing & Diagnostics Head office and Area Served
3.6 Global Key Players of Respiratory Disease Testing & Diagnostics, Product and Application
3.7 Global Key Players of Respiratory Disease Testing & Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Disease Testing & Diagnostics Breakdown Data by Type
4.1 Global Respiratory Disease Testing & Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Respiratory Disease Testing & Diagnostics Forecasted Market Size by Type (2024-2029)
5 Respiratory Disease Testing & Diagnostics Breakdown Data by Application
5.1 Global Respiratory Disease Testing & Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Respiratory Disease Testing & Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Respiratory Disease Testing & Diagnostics Market Size (2018-2029)
6.2 North America Respiratory Disease Testing & Diagnostics Market Size by Type
6.2.1 North America Respiratory Disease Testing & Diagnostics Market Size by Type (2018-2023)
6.2.2 North America Respiratory Disease Testing & Diagnostics Market Size by Type (2024-2029)
6.2.3 North America Respiratory Disease Testing & Diagnostics Market Share by Type (2018-2029)
6.3 North America Respiratory Disease Testing & Diagnostics Market Size by Application
6.3.1 North America Respiratory Disease Testing & Diagnostics Market Size by Application (2018-2023)
6.3.2 North America Respiratory Disease Testing & Diagnostics Market Size by Application (2024-2029)
6.3.3 North America Respiratory Disease Testing & Diagnostics Market Share by Application (2018-2029)
6.4 North America Respiratory Disease Testing & Diagnostics Market Size by Country
6.4.1 North America Respiratory Disease Testing & Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Respiratory Disease Testing & Diagnostics Market Size by Country (2018-2023)
6.4.3 North America Respiratory Disease Testing & Diagnostics Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Respiratory Disease Testing & Diagnostics Market Size (2018-2029)
7.2 Europe Respiratory Disease Testing & Diagnostics Market Size by Type
7.2.1 Europe Respiratory Disease Testing & Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Respiratory Disease Testing & Diagnostics Market Size by Type (2024-2029)
7.2.3 Europe Respiratory Disease Testing & Diagnostics Market Share by Type (2018-2029)
7.3 Europe Respiratory Disease Testing & Diagnostics Market Size by Application
7.3.1 Europe Respiratory Disease Testing & Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Respiratory Disease Testing & Diagnostics Market Size by Application (2024-2029)
7.3.3 Europe Respiratory Disease Testing & Diagnostics Market Share by Application (2018-2029)
7.4 Europe Respiratory Disease Testing & Diagnostics Market Size by Country
7.4.1 Europe Respiratory Disease Testing & Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Respiratory Disease Testing & Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe Respiratory Disease Testing & Diagnostics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Respiratory Disease Testing & Diagnostics Market Size (2018-2029)
8.2 China Respiratory Disease Testing & Diagnostics Market Size by Type
8.2.1 China Respiratory Disease Testing & Diagnostics Market Size by Type (2018-2023)
8.2.2 China Respiratory Disease Testing & Diagnostics Market Size by Type (2024-2029)
8.2.3 China Respiratory Disease Testing & Diagnostics Market Share by Type (2018-2029)
8.3 China Respiratory Disease Testing & Diagnostics Market Size by Application
8.3.1 China Respiratory Disease Testing & Diagnostics Market Size by Application (2018-2023)
8.3.2 China Respiratory Disease Testing & Diagnostics Market Size by Application (2024-2029)
8.3.3 China Respiratory Disease Testing & Diagnostics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Respiratory Disease Testing & Diagnostics Market Size (2018-2029)
9.2 Asia Respiratory Disease Testing & Diagnostics Market Size by Type
9.2.1 Asia Respiratory Disease Testing & Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia Respiratory Disease Testing & Diagnostics Market Size by Type (2024-2029)
9.2.3 Asia Respiratory Disease Testing & Diagnostics Market Share by Type (2018-2029)
9.3 Asia Respiratory Disease Testing & Diagnostics Market Size by Application
9.3.1 Asia Respiratory Disease Testing & Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia Respiratory Disease Testing & Diagnostics Market Size by Application (2024-2029)
9.3.3 Asia Respiratory Disease Testing & Diagnostics Market Share by Application (2018-2029)
9.4 Asia Respiratory Disease Testing & Diagnostics Market Size by Region
9.4.1 Asia Respiratory Disease Testing & Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Respiratory Disease Testing & Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia Respiratory Disease Testing & Diagnostics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Respiratory Disease Testing & Diagnostics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Respiratory Disease Testing & Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Respiratory Disease Testing & Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Respiratory Disease Testing & Diagnostics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Respiratory Disease Testing & Diagnostics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Respiratory Disease Testing & Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Respiratory Disease Testing & Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Respiratory Disease Testing & Diagnostics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Respiratory Disease Testing & Diagnostics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Respiratory Disease Testing & Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Respiratory Disease Testing & Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Respiratory Disease Testing & Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Respiratory Disease Testing & Diagnostics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Becton Dickinson
11.1.1 Becton Dickinson Company Details
11.1.2 Becton Dickinson Business Overview
11.1.3 Becton Dickinson Respiratory Disease Testing & Diagnostics Introduction
11.1.4 Becton Dickinson Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.1.5 Becton Dickinson Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Respiratory Disease Testing & Diagnostics Introduction
11.2.4 Abbott Laboratories Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.2.5 Abbott Laboratories Recent Developments
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Respiratory Disease Testing & Diagnostics Introduction
11.3.4 Abbott Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.3.5 Abbott Recent Developments
11.4 Cepheid
11.4.1 Cepheid Company Details
11.4.2 Cepheid Business Overview
11.4.3 Cepheid Respiratory Disease Testing & Diagnostics Introduction
11.4.4 Cepheid Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.4.5 Cepheid Recent Developments
11.5 Fischer and Paykel
11.5.1 Fischer and Paykel Company Details
11.5.2 Fischer and Paykel Business Overview
11.5.3 Fischer and Paykel Respiratory Disease Testing & Diagnostics Introduction
11.5.4 Fischer and Paykel Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.5.5 Fischer and Paykel Recent Developments
11.6 Futuremed
11.6.1 Futuremed Company Details
11.6.2 Futuremed Business Overview
11.6.3 Futuremed Respiratory Disease Testing & Diagnostics Introduction
11.6.4 Futuremed Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.6.5 Futuremed Recent Developments
11.7 Hoffmann-La Roche
11.7.1 Hoffmann-La Roche Company Details
11.7.2 Hoffmann-La Roche Business Overview
11.7.3 Hoffmann-La Roche Respiratory Disease Testing & Diagnostics Introduction
11.7.4 Hoffmann-La Roche Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.7.5 Hoffmann-La Roche Recent Developments
11.8 Instrumentation Laboratories
11.8.1 Instrumentation Laboratories Company Details
11.8.2 Instrumentation Laboratories Business Overview
11.8.3 Instrumentation Laboratories Respiratory Disease Testing & Diagnostics Introduction
11.8.4 Instrumentation Laboratories Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.8.5 Instrumentation Laboratories Recent Developments
11.9 Medtronic
11.9.1 Medtronic Company Details
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Respiratory Disease Testing & Diagnostics Introduction
11.9.4 Medtronic Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.9.5 Medtronic Recent Developments
11.10 NDD Medical Technologies
11.10.1 NDD Medical Technologies Company Details
11.10.2 NDD Medical Technologies Business Overview
11.10.3 NDD Medical Technologies Respiratory Disease Testing & Diagnostics Introduction
11.10.4 NDD Medical Technologies Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.10.5 NDD Medical Technologies Recent Developments
11.11 Nihon Kohden
11.11.1 Nihon Kohden Company Details
11.11.2 Nihon Kohden Business Overview
11.11.3 Nihon Kohden Respiratory Disease Testing & Diagnostics Introduction
11.11.4 Nihon Kohden Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.11.5 Nihon Kohden Recent Developments
11.12 Philips Medical Systems
11.12.1 Philips Medical Systems Company Details
11.12.2 Philips Medical Systems Business Overview
11.12.3 Philips Medical Systems Respiratory Disease Testing & Diagnostics Introduction
11.12.4 Philips Medical Systems Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.12.5 Philips Medical Systems Recent Developments
11.13 SDI Diagnostics
11.13.1 SDI Diagnostics Company Details
11.13.2 SDI Diagnostics Business Overview
11.13.3 SDI Diagnostics Respiratory Disease Testing & Diagnostics Introduction
11.13.4 SDI Diagnostics Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.13.5 SDI Diagnostics Recent Developments
11.14 Seegene
11.14.1 Seegene Company Details
11.14.2 Seegene Business Overview
11.14.3 Seegene Respiratory Disease Testing & Diagnostics Introduction
11.14.4 Seegene Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.14.5 Seegene Recent Developments
11.15 Smiths Medical
11.15.1 Smiths Medical Company Details
11.15.2 Smiths Medical Business Overview
11.15.3 Smiths Medical Respiratory Disease Testing & Diagnostics Introduction
11.15.4 Smiths Medical Revenue in Respiratory Disease Testing & Diagnostics Business (2018-2023)
11.15.5 Smiths Medical Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Becton Dickinson
Abbott Laboratories
Abbott
Cepheid
Fischer and Paykel
Futuremed
Hoffmann-La Roche
Instrumentation Laboratories
Medtronic
NDD Medical Technologies
Nihon Kohden
Philips Medical Systems
SDI Diagnostics
Seegene
Smiths Medical
听
听
*If Applicable.
